← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-10-19

Drug application

FDA Application #

ANDA209890

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2023-10-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown